Financial Performance - The company's operating revenue for Q1 2023 was ¥480,728,229.91, a decrease of 32.11% compared to ¥708,092,267.05 in the same period last year[2] - Net profit attributable to shareholders was ¥38,051,841.70, down 24.44% from ¥50,362,789.78 year-on-year[2] - The net profit after deducting non-recurring gains and losses was ¥37,015,418.33, a decline of 25.73% compared to ¥49,838,803.32 in the previous year[2] - The net profit for Q1 2023 was CNY 39,434,341.13, a decrease of 25.5% compared to CNY 52,972,030.29 in Q1 2022[16] - Operating profit for Q1 2023 was CNY 54,859,551.08, down 22.8% from CNY 71,179,878.70 in the same period last year[16] - The company reported a total comprehensive income of CNY 39,434,341.13 for Q1 2023, down from CNY 52,972,030.29 in Q1 2022[17] - Basic and diluted earnings per share for Q1 2023 were both CNY 0.37, compared to CNY 0.65 in the same quarter last year[17] Cash Flow and Assets - The net cash flow from operating activities increased by 15.94% to ¥31,628,830.36 from ¥27,279,947.33 in the same period last year[2] - Current assets totaled CNY 1,341,164,251.23, up from CNY 1,297,326,671.37, indicating an increase of about 3.4%[13] - The company's cash and cash equivalents decreased slightly to CNY 704,855,907.72 from CNY 713,120,722.97, a decline of about 1.0%[12] - The total cash and cash equivalents at the end of Q1 2023 were CNY 704,213,907.72, a decrease from CNY 188,659,154.18 at the end of Q1 2022[19] Liabilities and Equity - Total liabilities rose to CNY 562,973,683.48 from CNY 451,618,954.40, reflecting an increase of approximately 24.7%[14] - The company’s total liabilities increased, with borrowings received amounting to CNY 95,000,000.00 in Q1 2023, compared to CNY 85,563,550.00 in Q1 2022[19] - The total equity attributable to shareholders increased to CNY 1,670,308,112.83 from CNY 1,634,064,448.40, reflecting a growth of approximately 2.2%[14] Research and Development - Research and development expenses increased by 65.33% to ¥1,126,628.83 from ¥681,428.45 in the previous year[4] - Research and development expenses increased to CNY 1,126,628.83, up 65.3% from CNY 681,428.45 in Q1 2022[16] Shareholder Information - The controlling shareholder, Chen Yongfu, directly holds 30.81% of the company, while his spouse, Jin Ping, through Ningbo Yongtai Qintang Investment Partnership, indirectly controls an additional 6.31%, totaling 37.12%[7] - The total number of common shareholders at the end of the reporting period was 10,197, with the top ten shareholders holding a significant portion of shares[6] - The largest shareholder, Chen Yongfu, holds 32,000,000 shares, representing 30.81% of the total shares[6] - The company has a total of 6.32% of shares held by Ningbo Qiantai Investment Partnership and Ningbo Qianbang Investment Partnership, indicating a consolidated shareholder structure[8] - The company reported a total of 3,744,354 shares held by CITIC Bank's investment fund, reflecting strong institutional interest[10] - The company is actively managing its shareholder relationships, with several shareholders being identified as acting in concert, which may influence future corporate governance[8] Strategic Moves - The company acquired 100% equity of Shaoxing Changrun Chemical Co., Ltd. on February 9, 2023, as part of its expansion strategy[11] - The company plans to participate in the bankruptcy reorganization of Hongsheng Logistics, Hongsheng Technology, and Xin Hongsheng Chemical, indicating a strategic move to enhance its market position[11] - The company plans to use part of the raised funds to increase capital in its wholly-owned subsidiary to implement investment projects[11] Financial Expenses - The company incurred financial expenses of CNY 5,384,905.20, which is an increase from CNY 2,728,783.32 in Q1 2022[16] Foreign Exchange and Other Losses - The company reported a foreign exchange loss of ¥6,109,200 in Q1 2023, compared to a loss of ¥922,800 in the same period last year[2]
永泰运(001228) - 2023 Q1 - 季度财报(更正)